• Draper’s “DragonflEye” project—a genetically-modified dragonfly carrying a solar-powered, steerable backpack—was highlighted as a working cyborg drone; discussion centered on its biological control aspects more than its surveillance potential.  
• IEEE Spectrum article on DragonflEye (http://spectrum.ieee.org/automaton/robotics/drones/drapers-genetically-modified-cyborg-dragonfleye-takes-flight) was shared as the primary reference.  
• Participants debated the obsolescence of keyboard-based password entry, citing long-standing risks such as long-range video capture of keystrokes (referencing the 1992 film “Sneakers”) and photo-based key duplication.  
• NASA’s newest astronaut class announcement (https://www.nasa.gov/press-release/nasa-s-newest-astronaut-recruits-to-conduct-research-off-the-earth-for-the-earth-and) prompted tongue-in-cheek suggestions to send sharks or octopuses to Europa for astrobiology experiments.  
• Follistatin-344, a myostatin inhibitor, was discussed as a candidate DIY peptide; a commercial source (https://www.peptideswarehouse.com/shop/follistatin-344/) was linked, with skepticism about purity and the likelihood of receiving misfolded E. coli protein.  
• R&D Systems was recommended as a benchmark supplier for recombinant human follistatin, emphasizing the importance of expression system, endotoxin levels, and bioactivity data when sourcing research-grade proteins.